Latest Shareholder Approvals News

Simble Solutions has acquired exclusive rights to a cutting-edge 3D zinc oxide nanosensor technology and completed a $2.5 million placement, positioning itself to expand its IoT platform into new safety and environmental monitoring markets.

Argo Investments Limited has announced the renewal of its on-market buy-back facility, allowing the company to repurchase up to 37 million ordinary shares throughout 2026 as part of its capital management strategy.

Medallion Metals secures ASX waiver allowing its discounted Share Purchase Plan to proceed without shareholder approval, enabling retail investors to buy shares at the same price as institutions.

Vulcan Energy Resources has successfully closed its retail entitlement offer, raising €147 million and increasing HOCHTIEF's ownership to over 15%, eliminating the need for a conditional placement.

Omnia Metals Group has finalized its $1.58 million placement with the issue of 25 million shares and over 70 million options, setting the stage for renewed exploration and strategic growth.

RocketBoots Limited has successfully raised A$7 million through a placement to accelerate its international expansion following a transformative global contract. The capital injection aims to scale its AI-driven loss-prevention platform and convert a robust enterprise pipeline.

Enlitic has locked in commitments for an A$8 million convertible note capital raise, with initial funds arriving immediately and the remainder pending shareholder approval. This funding aims to extend the company’s runway as it advances its AI-driven healthcare solutions.

Corella Resources has completed the first tranche of a $1 million share placement, issuing over 142 million shares at $0.0035 each. The second tranche and attached options await shareholder approval in early 2026.

Global Uranium and Enrichment Limited has dispatched its Scheme Booklet to shareholders, marking a key step in Snow Lake Resources’ proposed acquisition. Shareholder and optionholder meetings are set for late January 2026 to vote on the transaction.

InhaleRx Limited has successfully closed its entitlement offer and placement, raising $857,730 to support the clinical development of inhaled treatments targeting cancer pain and mental health conditions.

Pure Resources has completed a $1.7 million placement to fund its Garnet Hills Garnet and Graphite Project, with options to be issued pending shareholder approval.

Next Science Limited has applied for voluntary delisting from the ASX following the sale of nearly all its assets to OSARTIS GmbH. The company proposes a capital return to shareholders and intends to commence winding up after delisting.